A view on antimicrobial resistance in developing countries and responsible risk factors
- PMID: 15288307
- DOI: 10.1016/j.ijantimicag.2004.02.015
A view on antimicrobial resistance in developing countries and responsible risk factors
Abstract
Antimicrobial resistance is one of the biggest challenges facing global public health. Although antimicrobial drugs have saved many lives and eased the suffering of many millions, poverty, ignorance, poor sanitation, hunger and malnutrition, inadequate access to drugs, poor and inadequate health care systems, civil conflicts and bad governance in developing countries have tremendously limited the benefits of these drugs in controlling infectious diseases. The development of resistance in the responsible pathogens has worsened the situation often with very little resource to investigate and provide reliable susceptibility data on which rational treatments can be based as well as means to optimise the use of antimicrobial agents. The emergence of multi-drug-resistant isolates in tuberculosis, acute respiratory infections and diarrhoea, often referred to as diseases of poverty, has had its greatest toll in developing countries. The epidemic of HIV/AIDS, with over 30 million cases in developing countries, has greatly enlarged the population of immunocompromised patients. The disease has left these patients at great risk of numerous infections and even greater risks of acquiring highly resistant organisms during long periods of hospitalisation. This review discusses antimicrobial resistance in developing countries and the risk factors responsible.
Similar articles
-
The role of poverty in antimicrobial resistance.J Am Board Fam Med. 2007 Nov-Dec;20(6):533-9. doi: 10.3122/jabfm.2007.06.070019. J Am Board Fam Med. 2007. PMID: 17954860 Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
Monitoring of antimicrobial resistance in pathogenic bacteria from livestock animals.Int J Med Microbiol. 2006 Jun;296 Suppl 41:81-6. doi: 10.1016/j.ijmm.2006.01.064. Int J Med Microbiol. 2006. PMID: 16530479
-
Antimicrobial resistance among neonatal pathogens in developing countries.Pediatr Infect Dis J. 2009 Jan;28(1 Suppl):S19-21. doi: 10.1097/INF.0b013e3181958780. Pediatr Infect Dis J. 2009. PMID: 19106758 Review.
-
Pets and antimicrobial resistance.Vet Clin North Am Small Anim Pract. 2009 Mar;39(2):279-92. doi: 10.1016/j.cvsm.2008.10.016. Vet Clin North Am Small Anim Pract. 2009. PMID: 19185194 Review.
Cited by
-
Drivers of Antibiotic Resistance Transmissionin Low- and Middle-Income Countriesfrom a "One Health" Perspective-A Review.Antibiotics (Basel). 2020 Jul 1;9(7):372. doi: 10.3390/antibiotics9070372. Antibiotics (Basel). 2020. PMID: 32630353 Free PMC article. Review.
-
Antimicrobial Resistance Creates Threat to Chimpanzee Health and Conservation in the Wild.Pathogens. 2021 Apr 14;10(4):477. doi: 10.3390/pathogens10040477. Pathogens. 2021. PMID: 33920028 Free PMC article.
-
Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.Biochemistry. 2007 Aug 7;46(31):9058-67. doi: 10.1021/bi700688x. Epub 2007 Jul 14. Biochemistry. 2007. PMID: 17630785 Free PMC article.
-
Characterizing Shigella species distribution and antimicrobial susceptibility to ciprofloxacin and nalidixic acid in Latin America between 2000-2015.PLoS One. 2019 Aug 2;14(8):e0220445. doi: 10.1371/journal.pone.0220445. eCollection 2019. PLoS One. 2019. PMID: 31374081 Free PMC article.
-
[Diagnosis of streptococcal pharyngotonsillitis in children and adolescents: clinical picture limitations].Rev Paul Pediatr. 2014 Dec;32(4):285-91. doi: 10.1016/j.rpped.2014.04.001. Rev Paul Pediatr. 2014. PMID: 25510990 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
